(3R,4R)-tert-Butyl 3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine-1-carboxylate

Catalog No. :
ACOULG871
CAS No. :
1622258-77-8
Molecular Formula :
C24H28FNO5
Molecular Weight :
429.49

IUPAC Name:tert-butyl (3R,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine-1-carboxylate

(3R,4R)-tert-Butyl 3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$669.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(3R,4R)-tert-Butyl 3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine-1-carboxylate
IUPAC Nametert-butyl (3R,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine-1-carboxylate
Molecular FormulaC24H28FNO5
Molecular Weight429.49
SMILESO=C(N1C[C@H](COC2=CC=C(OCO3)C3=C2)[C@H](C4=CC=C(F)C=C4)CC1)OC(C)(C)C
InChI KeyVMVWGBILQKUTEF-XLIONFOSSA-N
Synonym1-Piperidinecarboxylic acid, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, 1,1-dimethylethyl ester, (3R,4R)-rel-;cis-tert-butyl 3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine-1-carboxylate
CAS No.1622258-77-8

Synthetic Route by SureRoute

1. ACOULG871 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACISZQ329 route compound structure diagram
    ACISZQ329533-31-3 In Stock
  4. Then
  5. ACOULG871 route product structure diagram
    ACOULG8711622258-77-8
Inquiry

2. ACOULG871 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACISZQ329 route compound structure diagram
    ACISZQ329533-31-3 In Stock
  4. Then
  5. ACOULG871 route product structure diagram
    ACOULG8711622258-77-8
Inquiry

Comments (0)